Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




New Device Conserves Blood During Surgery

By HospiMedica International staff writers
Posted on 22 Jun 2020
A novel vacuum device effectively automates the manual activity of surgical sponge-blood recovery for intraoperative auto transfusion (IAT).

The ProCell Surgical (Canton, MA, USA) ProCell is a sterile, compact and disposable medical device that comes fully assembled and includes just three components. To operate ProCell, up to five surgical sponges are placed inside the open basket and the lid is placed back in place. As OR vacuum suction tubing is connected, the lid is automatically deployed in a downward direction, which extracts the blood from the sponges. The collected blood is then sent back to the IAT equipment for processing by suctioning the blood from the reservoir via cannula.

The recovered blood is then reinfused from the IAT via its own suction tubing into the patient during that same surgical procedure. ProCell does not filter or otherwise process the blood collected in any way, and can be used up to 50 times during a single surgical case, processing up to 20 12” X 12” surgical sponges; it cannot be reprocessed for reuse. In addition to automating IAT and reducing the need for blood transfusions, ProCell also reduces potential occupational health hazards associated with hand-wringing, such as operator hand fatigue and messy blood splatter on surgical gloves and the OR area.

“ProCell Surgical's sponge blood recovery system brings the first automated innovation for sponge-blood recovery directly to the operating room table,” said co-inventor Robert Krensky, MD, CEO of ProCell Surgical. “It is easy to operate and can be used repeatedly during its single case use. ProCell essentially closes the technology gap that existed during this important preliminary phase of IAT.”

Unlike IAT, using transfused blood products beyond a level deemed medically necessary can increase complication rates, intensive care unit (ICU) stays, and overall length of hospitalization. Overuse can also substantially increase the cost of care, since the cost of a single unit of red blood cells (RBCs) can reach as high as USD 1,100 (when administration and supply costs are included).

Related Links:
ProCell Surgical


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Vital Signs Monitor
iM3s
New
Auditory Evoked Potential Device
Bio-logic NavPRO ONE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.